Safety and Immunogenicity of rVSVΔG-ZEBOV-GP Vaccination When Dosed Concurrently With mRNA COVID-19 Vaccine Booster Doses

NCT06587503 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Ebola Virus Disease
COVID-19

Interventions

BIOLOGICAL: BioNTech - Pfizer COVID-19 vaccine
BIOLOGICAL: 1mL saline solution
BIOLOGICAL: rVSV∆G-ZEBOV-GP

Sponsor

University of Birmingham

Collaborators

[object Object]
[object Object]
[object Object]